Case Report (n=1)
This case report highlights the challenges of managing severe recurrent acute coronary syndromes in a patient with salicylate allergy, demonstrating the limitations of repeated percutaneous coronary interventions.
Answers are grounded in this paper and cite their sources.
Recurrent ACS despite 11 stents highlights PCI limits; leaves open optimal strategies in salicylate-allergic patients.
We present the case of a 65-year-old man with type 2 diabetes mellitus, arterial hypertension, hypercholesterolemia, salicylate allergy and diagnosed with ischemic heart disease since 2000. The patient, despite intensive pharmacotherapy according to European Society of Cardiology guidelines and the insertion of as many as 11 stents into the coronary arteries, had persistent recurrent acute coronary syndromes, including 4 myocardial infarctions (twice ST-elevation myocardial infarction, twice non-ST-elevation myocardial infarction) between 2000 and 2021. Eventually, the patient underwent left coronary artery bypass surgery. Some potential options for the pharmacological treatment of recurrent acute coronary syndromes are presented in the discussion.
No takes yet. Share an insight, caveat, or question.
Bralewska et al. (2023) conducted a case report in Coronary artery disease (n=1). Percutaneous coronary intervention (stent implantation) was evaluated on Recurrent acute coronary syndromes.
Synapse has enriched 10 related papers. Consider them for comparative context: